Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?

After almost a decade of stagnation in clinical research for HF treatment, five large randomized trials recently published have supported the use of four new classes of drugs, namely: angiotensin receptor/neprilysin inhibitor, sodium–glucose co-transporters 2 inhibitors, soluble guanylate cyclase mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fucili, Alessandro, Cimaglia, Paolo, Severi, Paolo, Giannini, Francesco, Boccadoro, Alberto, Micillo, Marco, Rapezzi, Claudio, Tavazzi, Luigi, Ferrari, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509308/
https://www.ncbi.nlm.nih.gov/pubmed/34640341
http://dx.doi.org/10.3390/jcm10194325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509308/
https://www.ncbi.nlm.nih.gov/pubmed/34640341
http://dx.doi.org/10.3390/jcm10194325

Ejemplares similares